SEC 13F Intelligence

Tudor Investment Corp Et Al / CELG

Tudor Investment Corp Et Al’s Celgene Corp Position

Does Tudor Investment Corp Et Al own Celgene Corp (CELG)? Not currently — the last reported position was 1.29M shares worth $128M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$128M
Q3 2019
Shares
1.29M
% of Portfolio
+4.40%
Quarters Held
4
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $901,000Q4 ’18Q1 ’19: $114MQ1 ’19Q2 ’19: $104MQ2 ’19Q3 ’19: $128MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20191.29M$128M+4.40%
Q2 20191.12M$104M+2.95%
Q1 20191.20M$114M+4.70%
Q4 201814.1K$901,000+0.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tudor Investment Corp Et Al’s full portfolio or all institutional holders of CELG.